CEPI backs three vaccine programs targeting Bundibugyo Ebola amid outbreak in DR Congo and Uganda
The Facts
- CEPI is funding or accelerating development of three investigational vaccines against the Bundibugyo species of Ebola.
- The three vaccine efforts involve IAVI, Moderna, and the University of Oxford.
- The current Bundibugyo Ebola outbreak is centered in eastern Democratic Republic of Congo and has also been reported in Uganda.
- There is no approved or licensed vaccine for Bundibugyo Ebola.
- The outbreak has caused roughly 246 to nearly 250 deaths and more than 1,000 suspected cases, according to reports citing health authorities.
- Because no approved Bundibugyo vaccine exists, health agencies are prioritizing experimental vaccines and treatments for evaluation through clinical trials.
- The vaccine effort is intended to speed testing and, if candidates work, support faster availability of doses for outbreak response.
How left and right are reading this
- Both agree
- A deadly Bundibugyo outbreak is unfolding without any approved vaccine, making accelerated clinical testing of investigational candidates a necessary response if health agencies are to turn promising research into usable outbreak-control doses.
- They split on
- Less a disagreement than a question of emphasis: the injustice of leaving affected communities exposed without protection, versus the discipline of relying on clinical trials before treating any candidate as a real solution.
Analytical frames for this storyTap to explore
Context
Why can't existing Ebola vaccines simply be used for this outbreak?
Sources say Ebola vaccines are species-specific. There is a vaccine for the Zaire species, but this outbreak is caused by the Bundibugyo species, for which no approved vaccine currently exists BBC,NDTV.
What has the WHO said about using vaccines and treatments in this outbreak?
The WHO said expert groups reviewed promising vaccine and treatment candidates for Bundibugyo and recommended that identified products be used only within clinical trials so researchers can gather robust safety and effectiveness data RTBF,BFMTV.
What funding has been announced so far?
Reuters reported that CEPI is providing roughly $60 million across the three vaccine efforts, including up to $50 million for Moderna, while Gavi separately approved a $50 million outbreak-response fund, with $40 million earmarked to support vaccine development and readiness Reuters,Deutsche Welle.
View all 100 sources
Wire services (12)
Independent coverage (50)
FirstpostAs US withdraws, India & non-profits pitch in to help DRC ta...
NewsBytes3 Ebola vaccines being developed amid outbreak in Africa
Der TagesspiegelIm Kampf gegen Ebola: Moderna entwickelt mRNA-Impfstoff gege...
NDTVEbola Vaccine Race Intensifies With Fund Surge, But Doctors ...
Qué!"Hasta finales de 2021 no habrá una vacunación global"
NewsBytesSerum Institute to manufacture Ebola vaccine developed by Ox...
NewZimbabwe.comThree Ebola vaccines in development amid growing outbreak fe...
Bizcommunity.comCEPI's $60m speeds up race to develop Ebola Bundibugyo vacci...
New VisionHealth: Three experimental Ebola Bundibugyo vaccines being f
KBC | Kenya's WatchingThree Ebola vaccines in development amid growing outbreak fe...
Economic TimesSerum Institute of India to manufacture Oxford Ebola vaccine...
Economic TimesModerna and other groups get $60 million to develop Ebola va...
The Nation ThailandCEPI sets aside about US$60 million for Bundibugyo Ebola vac...
Sunday WorldModerna and other groups get $60m to develop Ebola vaccine
The News InternationalNew Ebola vaccines fast-tracked amid fears of worst outbreak...
The StarEDITORIAL: WHO right to insist that all Ebola vaccines remai...
The Korea HeraldModerna and other groups get $60 million to develop Ebola va...
UrduPointInternational Efforts Accelerate Development Of Vaccine Agai...
lunaticoutpost.comModerna Snags $50 Million Ebola Vax Contract
MyJoyOnline.comModerna and other groups get $60 million to develop Ebola va...
Australian Broadcasting CorporationRace to develop Ebola vaccine as deadly strain of virus spre...
El Financiero¿Qué sabemos de las 3 vacunas contra la cepa que provoca el ...
100 Percent Fed UpModerna Lands $50 Million Investment To Develop mRNA Ebola J...
STATGlobal coalition to fast-track 3 vaccines targeting Ebola ou...
Ars TechnicaModerna gets $50 million to develop mRNA Ebola vaccine again...
BAE NegociosLa OMS acelera el desarrollo de vacunas contra el ébola Bund...
The HillModerna gets $50M investment for Ebola vaccine candidate
Corse MatinEbola : les efforts s'intensifient au niveau mondial pour tr...
Periódico El DíaTres vacunas contra el Ébola en desarrollo en medio de creci...
Arab NewsModerna and other groups get $60m to develop Ebola vaccine
cnbctv18.comModerna and other groups get $60 million to develop Ebola va...
lindependant.frEbola : les efforts s'intensifient pour mettre rapidement au...
The StarThree Ebola vaccines in development amid growing outbreak fe...
Pulse24.com Moderna and other groups get US$60 million to develop Ebola ...
SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.Moderna, other groups get $60 million to develop Ebola vacci...
Prensa latinaAnuncian financiamiento a tres candidatas de vacuna contra é...
midilibre.frÉpidémie d'Ebola : course contre la montre mondiale pour tro...
Asharq Al-Awsat English'We Need to Act Now': Race to Develop Ebola Vaccine Heats Up
UDG TVAlianza para las vacunas aprueba fondos para desarrollar vac...
RT en FrançaisEbola : Moderna s'associe à une coalition mondiale pour déve...
ExcélsiorSe asocian Moderna y CEPI para la vacuna contra el ébola de ...
TV5MONDE"Agir dès maintenant": les efforts s'intensifient pour un va...
InfosalusGavi destina 43 millones de euros a acelerar el acceso a vac...
RTL Today'We need to act now': Race to develop Ebola vaccine heats up
BBCThree Ebola vaccines in development amid growing outbreak fe...
BBCThree Ebola vaccines in development amid growing outbreak fe...
EL PAÍSTres vacunas en la carrera contra el ébola Bundibugyo
www.theepochtimes.com$60 Million Pledged to Fast-Track Ebola Vaccines
Gaceta MédicaGavi destina 50 millones de dólares a las vacunas contra el ...
El EconomistaCEPI dará 60 millones de dólares a Moderna y otros grupos pa...
About these frames
The First Responder: Who gets hurt or helped. Quality of life, vulnerable groups, public health, human cost and benefit.
The Architect: Stability, law, enforcement, institutional design, separation of powers, regulatory process, rule of law. How are order and governance maintained?
The Analyst: Costs, jobs, inflation, growth, incentives, markets, tradeoffs. Follow the money.
See this differently than someone you know would? Two ways to keep it going.
The dial works on any URL — paste an article you read elsewhere this week.